<SEC-DOCUMENT>0001213900-23-036960.txt : 20230505
<SEC-HEADER>0001213900-23-036960.hdr.sgml : 20230505
<ACCEPTANCE-DATETIME>20230505171757
ACCESSION NUMBER:		0001213900-23-036960
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230505
DATE AS OF CHANGE:		20230505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mawson Infrastructure Group Inc.
		CENTRAL INDEX KEY:			0001218683
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		IRS NUMBER:				880445167
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264062
		FILM NUMBER:		23895025

	BUSINESS ADDRESS:	
		STREET 1:		201 CLARK STREET
		CITY:			SHARON
		STATE:			PA
		ZIP:			16146
		BUSINESS PHONE:		61 02 8624 6130

	MAIL ADDRESS:	
		STREET 1:		201 CLARK STREET
		CITY:			SHARON
		STATE:			PA
		ZIP:			16146

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wize Pharma, Inc.
		DATE OF NAME CHANGE:	20171120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OphthaliX, Inc.
		DATE OF NAME CHANGE:	20120207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENALI CONCRETE MANAGEMENT INC
		DATE OF NAME CHANGE:	20030213
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ea178054-424b3_mawsoninfra.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-264062</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS SUPPLEMENT<BR>
(To prospectus dated April 11, 2022)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MAWSON INFRASTRUCTURE GROUP INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>8,000,000 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Common Stock Warrants to Purchase 10,000,000Shares
of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Placement Agent Warrants to Purchase 560,000
Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus supplement modifies, supersedes and supplements certain
information contained in, and should be read in conjunction with, our prospectus (the &ldquo;Original Prospectus&rdquo;), dated July 19,
2022, which is part of a registration statement on Form S-3, as amended, originally filed with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) on April 1, 2022, and declared effective by the SEC on April 11, 2022, related to the offering, among other securities,
of warrants issued July 20, 2022, to purchase up to 10,000,000 shares of our common stock (the &ldquo;Existing Warrants&rdquo;) at an
exercise price of $1.01 per share. Since issuance, the number of shares subject to the Existing Warrants and the exercise price automatically
adjusted to 1,666,667 shares and $6.06 per share, respectively, upon our 1-for-6 reverse stock split in February of 2023. The Existing
Warrants have now been amended as described below under &ldquo;Amendments to Existing Warrants.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus supplement should be read in conjunction with the Original
Prospectus, and is qualified by reference to the Original Prospectus, except to the extent that the information presented herein supersedes
the information contained in the Original Prospectus. This prospectus supplement is not complete without, and may only be delivered or
used in connection with, the Original Prospectus, including any amendments or supplements thereto. We may amend or supplement the Original
Prospectus from time to time by filing amendments or supplements as required. You should read the entire Original Prospectus and any amendments
or supplements carefully before you make an investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our common stock is listed on The Nasdaq Capital Market under the symbol
&ldquo;MIGI.&rdquo; The closing price of our Common Stock on May 3, 2023, as reported by Nasdaq, was $3.23 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investing in our securities involves a high degree of risk. Before
making any investment in these securities, you should consider carefully the risks and uncertainties in the section entitled &ldquo;Risk
Factors&rdquo; beginning on page S-4 of the Original Prospectus and in the other documents that are incorporated by reference therein
and any related free writing prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS SUPPLEMENT IS ACCURATE, TRUTHFUL OR COMPLETE.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENTS TO EXISTING WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 3, 2023, in connection with a securities purchase agreement
entered into by us with certain institutional investors dated May 3, 2023 (&ldquo;Purchase Agreement&rdquo;), we filed a prospectus supplement
(the &ldquo;Registered Direct Prospectus Supplement&rdquo;) and the accompanying base prospectus with the SEC under our registration statement
on Form S-3 (Registration No. 333-264062) in accordance with Rule 424(b)(5) of the Securities Act of 1933, as amended. Pursuant to the
securities purchase agreement and the Registered Direct Prospectus Supplement, we offered and sold an aggregate of 2,083,336 shares of
our common stock (or prefunded warrants in lieu thereof). In a concurrent private placement, we also issued unregistered warrants to purchase
up to 2,604,170 shares of our common stock at an exercise price of $3.23 per share of common stock. The issuances above are collectively
referred to herein as the &ldquo;Offering.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus supplement is being filed to disclose the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Offering, we entered into a Warrant Amendment
Agreement with an investor in the Offering (the &ldquo;Participating Investor&rdquo;) pursuant to which, in consideration for such Participating
Investor&rsquo;s purchase of securities in the Offering (the &ldquo;Purchase Commitment&rdquo;), we agreed to reduce the exercise price
of the Existing Warrants held by the Participating Investor to $3.23 per share, the exercise price of the warrants sold in the Offering,
and to extend the date of termination of the Existing Warrants to five and one-half years after the close of the Offering, and the Participating
Investor agreed that the Existing Warrants will not be exercisable until the date that is six months after the closing of the Offering.
No other changes to the Existing Warrants were made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus supplement is May 3, 2023.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
